Axonal transport defects: A common theme in neurodegenerative diseases

Acta Neuropathologica

Volumn 109, Issue 1, 2005, Pages 5-13

  Roy, Subhojit ^a   Zhang, Bin ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Axonal transport; Frontotemporal dementias; Parkinson's disease; Polyglutamine diseases

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; BETA SYNUCLEIN; BRAIN PROTEIN; CYTOPLASM PROTEIN; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3BETA; HUNTINGTIN; KINESIN; MOLECULAR MOTOR; NEUROFILAMENT PROTEIN; POLYGLUTAMINE; RNA; SPASTIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DEMENTIA; DOWN SYNDROME; EXPERIMENTAL MODEL; GENE MUTATION; GENETIC CODE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; MISSENSE MUTATION; MOLECULAR BIOLOGY; MOTOR NEURON DISEASE; NERVE FIBER TRANSPORT; NEURITE; NEUROPATHOLOGY; NEUROPIL; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; SHY DRAGER SYNDROME; TAUOPATHY; TRINUCLEOTIDE REPEAT;

ANIMALS; AXONAL TRANSPORT; HUMANS; MICROTUBULE PROTEINS; MODELS, NEUROLOGICAL; MUTATION; NEURODEGENERATIVE DISEASES;

EID: 14244261725     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-004-0952-x     Document Type: Review

References (53)

1. Baas PW (2002) Microtubule transport in the axon. Int Rev Cytol 212:41-62 1:CAS:528:DC%2BD38XhvF2qu7k%3D
2. Baas PW, Brown A (1997) Slow axonal transport: The polymer transport model. Trends Cell Biol 7:380-384 10.1016/S0962-8924(97)01148-3
3. Ben Othmane KB, Middleton LT, Loprest LJ, Wilkinson KM, Lennon F, Rozear MP, Stajich JM, Gaskell PC, Roses AD, Pericak-Vance MA, Vance JM (1993) Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 17:370-375 10.1006/geno.1993.1334
4. Benstead TJ, Grant IA (2001) Progress in clinical neurosciences: Charcot-Marie- Tooth disease and related inherited peripheral neuropathies. Can J Neurol Sci 28:199-214 1:STN:280:DC%2BD3Mvmsl2hsA%3D%3D
5. Brown A (2003) Axonal transport of membranous and nonmembranous cargoes: A unified perspective J Cell Biol 160:817-821 (See also the animation of axonal transport that accompanies this paper at http://www.jcb.org/cgi/content/full/jcb.200212017/DC1)
6. Deacon SW, Serpinskaya AS, Vaughan PS, Fanarraga ML, Vernos I, Vaughan KT, Gelfand VI (2003) Dynactin is required for bidirectional organelle transport. J Cell Biol 160: 297-301 10.1083/jcb.200210066
7. Duda JE, Giasson BI, Mabon M, Lee VM-Y, Trojanowski JQ (2002) Novel antibodies to oxidized alpha-synuclein reveal abundant neuritic pathology in Lewy body diseases. Ann Neurol 52:205-210 10.1002/ana.10279
8. Ferreira A, Caceres A, Kosik KS (1993) Intraneuronal compartments of the amyloid precursor protein. J Neurosci 13:3112-3123
9. Forman MS, Trojanowski JQ, Lee VM-Y (2004) Neurodegenerative diseases: A decade of revolutionary discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055-1063
10. Gajdusek DC (1985) Hypothesis: Interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system. N Engl J Med 312:714-719
11. Gunawardena S, Goldstein LS (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32:389-401 10.1016/S0896-6273(01)00496-2
12. Gunawardena S, Goldstein LS (2004) Cargo-carrying motor vehicles on the neuronal highway: Transport pathways and neurodegenerative disease. J Neurobiol 58:258-271 10.1002/neu.10319
13. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772-1775 1:CAS:528:DyaK2cXksFGisbk%3D
14. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, Lalli G, Witherden AS, Hummerich H, Nicholson S, et al. (2003) Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300:808-812 10.1126/science.1083129
15. Hazan J, Fonknechten N, Mavel D, Paternotte C, Samson D, Artiguenave F, Davoine CS, Cruaud C, Durr A, Wincker P, et al. (1999) Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 23:296-303 10.1038/15472
16. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, et al. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914-1917 10.1126/science.282.5395.1914
17. Higuchi M, Lee VM-Y, Trojanowski JQ (2002) Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2:131-150 10.1385/ NMM:2:2:131
18. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VM-Y (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice engineered to overexpress the shortest human tau isoform. Neuron 24:751-762 10.1016/S0896-6273(00)81127-7
19. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M (1998) Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. 273:26292-26294
20. Jensen PH, Li JY, Dahlstrom A, Dotti CG (1999) Axonal transport of synucleins is mediated by all rate components. Eur J Neurosci 11:3369-3376
21. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (1993) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. J Neurosci 13:3112-3123
22. King SJ, Schroer TA (2000) Dynactin increases the processivity of the cytoplasmic dynein motor. Nat Cell Biol 2:20-24
23. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport Proc Natl Acad Sci USA 87:1561-1565
24. Kotzbauer P, Giasson B, Kravitz A, Golbe LI, Mark MH, Trojanowski JQ, Lee, VM-Y (2004) In vitro and postmortem brain studies link fibrillization of both alpha-synuclein and tau to familial Parkinson's disease caused by the A53T alpha-synuyclein mutation. Exp Neurol 187:279-288 10.1016/j.expneurol.2004.01.007
25. LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascano J, Tokito M, Van Winkle T, Howland DS, Holzbaur EL (2002) Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34:715-727 10.1016/S0896-6273(02)00696-7
26. Lasek RJ, Garner JA, Brady ST (1984) Axonal transport of the cytoplasmic matrix. J Cell Biol 99:212-221 10.1083/jcb.99.1.212s
27. Lee VM-Y, Daughenbaugh R, Trojanowski JQ (1994) Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol Aging 15:S87-S89 10.1016/0197-4580(94)90179-1
28. Li W, Hoffman PN, Stirling W, Price DL, Lee MK (2004) Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations. J Neurochem 88:401-410 1:CAS:528:DC%2BD2cXntlSquw%3D%3D
29. McDermott CJ, White K, Bushby K, Shaw PJ (2000) Hereditary spastic paraparesis: A review of new developments. J Neurol Neurosurg Psychiatry 69:150-160 10.1136/jnnp.69.2.150
30. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST (2002) Glycogen synthase kinase-3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21:281-293 10.1093/emboj/ 21.3.281
31. Muresan V (2000) One axon, many kinesins: What's the logic? J Neurocytol 29:799-818
32. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20:3214-3220 1:CAS:528:DC%2BD3cXivFKhtL4%3D
33. Nakagawa T, Tanaka Y, Matsuoka E, Kondo S, Okada Y, Noda Y, Kanai Y, Hirokawa N (1997) Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. Proc Natl Acad Sci USA 94:9654-9659
34. Norris EH, Giasson BI, Lee VM (2004) Alpha-synuclein: Normal function and role in neurodegenerative diseases. Curr Top Dev Biol 60:17-54 15094295
35. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J (2003)Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci 23:4499-4508
36. Prudhomme JF, Brice A, Fontaine B, Heilig B, Weissenbach J (1999) Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 23:296-303 10.1038/15472
37. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, et al (2003) Mutant dynactin in motor neuron disease. Nat Genet 33:455-456
38. Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, Graham FL, Gaskell PC, Dearlove A, Pericak-Vance MA, et al. (2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71:1189-1194 10.1086/344210
39. Roy S, Coffee P, Smith G, Liem RKH, Brady ST, Black MM (2000) Neurofilaments are transported rapidly but intermittently in axons: Implications for slow axonal transport. J Neurosci 20:6849-6861
40. Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, Stenoien DL, Young M, Faber PW, MacDonald ME, McPhaul MJ, Brady ST (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40:41-52 10.1016/S0896-6273(03)00569-5
41. Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, Nihonmatsu N, Mercken M, Yamaguchi H, Sugihara S, Wolozin B (1998) Presenilin 1 associates with glycogen synthase kinase-3 beta and its substrate tau. Proc Natl Acad Sci USA 95:9637-9641
42. Tesseur I, Van Dorpe J, Bruynseels K, Bronfman F, Sciot R, Van Lommel A, Van Leuven F (2000) Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol 157:1495-1510 1:CAS:528:DC%2BD3cXosFyhsrw%3D
43. Trojanowski JQ, Mattson MP (2003) Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses. Neuromolecular Med 4:1-6
44. Trojanowski JQ, Ishihara T, Higuchi M, Yoshiyama Y, Hong M, Zhang B, Forman MS, Zhukareva V, Lee VM-Y (2002) Amyotrophic lateral sclerosis/ parkinsonism dementia complex: Transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam. Exp Neurol 176:1-11
45. Vale RD (2003) The molecular motor toolbox for intracellular transport. Cell 112:467-480 10.1016/S0092-8674(03)00111-9
46. Verhey KJ, Meyer D, Deehan R, Blenis J, Schnapp BJ, Rapoport TA, Margolis B (2001) Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J Cell Biol 152:959-970 10.1083/jcb.152.5.959
47. Wang L, Ho C-L, Sun D, Liem RKH, Brown A (2000) Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat Cell Biol 2:137-141
48. Waterman-Storer CM, Karki S, Kuznetsov SA, Tabb JS, Weiss DG, Langford GM, Holzbaur ELF (1997) The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. Proc Natl Acad Sci USA 94:12180-12185
49. Williamson TL, Cleveland DW (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2:50-56
50. Zhang B, Tu P-H, Abtahian F, Trojanowski JQ, Lee VM-Y (1997) Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol 139:1307-1315 10.1083/jcb.139.5.1307
51. Zhang B, Higuchi M, Yoshiyama Y, Forman MS, Ishihara T, Hong M, Trojanowski JQ, Lee VM-Y (2004) Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J Neurosci 24:4657-4667
52. Zhang B, Maiti A, Shively S, Lakhani F, McDonald-Jones G, Bruce J, Lee EB, Xie SX, Joyce S, Li C, Toleikis PM, et al. (2004) Microtubule binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a murine neurodegenerative tauopathy model. Proc Natl Acad Sci (in press)
53. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105:587-597 10.1016/S0092-8674(01)00363-4